Cargando…
Metformin is a novel suppressor for transforming growth factor (TGF)-β1
Metformin is a widely used first-line antidiabetic drug that has been shown to protect against a variety of specific diseases in addition to diabetes, including cardiovascular disorders, polycystic ovary syndrome, and cancer. However, the precise mechanisms underlying the diverse therapeutic effects...
Autores principales: | Xiao, Han, Zhang, Jianshu, Xu, Zhonghe, Feng, Yenan, Zhang, Mingliang, Liu, Jianli, Chen, Ruifei, Shen, Jing, Wu, Jimin, Lu, Zhizhen, Fang, Xiaohong, Li, Jingyuan, Zhang, Youyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923858/ https://www.ncbi.nlm.nih.gov/pubmed/27349853 http://dx.doi.org/10.1038/srep28597 |
Ejemplares similares
-
Metformin prevents peritendinous fibrosis by inhibiting transforming growth factor-β signaling
por: Zheng, Wei, et al.
Publicado: (2017) -
Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR
por: Yin, Qian, et al.
Publicado: (2016) -
Transforming Growth Factor (TGF) β and Endometrial Vascular Maturation
por: Lu, Qinsheng, et al.
Publicado: (2021) -
Expression of transforming growth factor-β (TGF-β) in chronic idiopathic cough
por: Xie, Shaoping, et al.
Publicado: (2009) -
The Transforming Growth Factor-β1 (TGF-β1) Gene Polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and Susceptibility to Postmenopausal Osteoporosis: A Meta-Analysis
por: Sun, Jiajia, et al.
Publicado: (2015)